Figure 6.
In vitro cytotoxicity assay. In vitro cytotoxic response of BM MNCs from 12 patients quantified by MTS assay after 72 hours of incubation with a range of concentrations of lestaurtinib. The trial number and clinical response status of each patient is indicated to facilitate comparison with Tables 2 and 5 and Figure 5.